Ether, Dogecoin Surge, Outpaces Bitcoin as DeFi Comments Spurs Bullish Mood
Bitcoin BTC stayed steady above $109,500 in Asian morning hours Wednesday, a rebound that started after last week's profit-taking.
However, all eyes are on ether ETH with traders commenting on upside volatility in the weeks to come and reporting record volumes for certain ETH-based products on some exchanges. ETH zoomed 5% in the past 24 hours, leading gains among majors.
'Investors are finally recognizing the compelling investment opportunity that Ethereum presents. It's still trading well below its all-time highs, while bitcoin is already near its ATH levels,' said Jeff Mei, COO at BTSE, in a message to CoinDesk.
He pointed to Ethereum's growing role in tokenizing real-world assets like stocks, money-market funds, and U.S. Treasuries, adding that it was 'very likely that Ethereum will reach and/or surpass its all-time high price by the end of the year.'
Ether ETFs have attracted more than $800 million in the past two weeks alone, outpacing bitcoin's sub-$400 million, according to SoSoValue data. That's helped the spread between ether's implied volatility and bitcoin's reach its highest level since late 2022 — a sign traders expect bigger price swings ahead.
Open interest in ether perpetuals on Kraken hit an all-time high of 30,000 ETH this week, said Alexia Theodorou, Head of Derivatives at Kraken, in an email to CoinDesk.
'This signals a notable uptick in speculative activity around the second-largest cryptocurrency by market cap,' she noted. However, she cautioned that the market 'has yet to form a clear directional consensus,' with the long/short ratio still well below January levels.
Elsewhere in the market, Solana SOL and Cardano ADA posted gains of 4.7% and 3.3%, respectively, adding to the risk-on tone, while XRP XRP rose 2% to $2.30. Ethereum beta bet dogecoin DOGE climbed 3.7% to reverse all of last week's losses.
Traders are closely watching upcoming U.S. CPI data on Wednesday, which could sway Federal Reserve rate expectations and shape risk sentiment ahead of next week's meeting.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Eater
an hour ago
- Eater
Mission Chinese Founder Takes Surprise Gig at Buddakan
Nearly two decades after pan-Asian clubstaurant Buddakan made its flashy Meatpacking District debut, Starr Restaurant Group is turning to a big-name chef to reinvent it. Mega-restaurateur Stephen Starr tapped Danny Bowien, of Mission Chinese Food fame, 'to revitalize the menu at Buddakan and give it a fresh look,' a Starr rep tells Eater. The team declined to say whether Bowien is a newly named co-owner or partner, as 'it's still in extremely early development stages.' The Substack Feed Me first flagged Bowien's incoming involvement this week. Bowien is best known for his San Francisco-born smash hit Mission Chinese, which expanded to New York in 2012 to instant acclaim. Subsequent locations followed on the Lower East Side and Bushwick. The restaurant group's reputation took a turn after employees repeatedly alleged a range of misconduct at the LES location, including racial discrimination as well as physical and verbal abuse. In 2022, Mission Chinese pulled out of NY completely. Bowien's neon-lit millennial magnet made a surprise NY comeback last spring, this time in the heart of Chinatown, as a nighttime residency inside Cha Kee (43 Mott Street, at Bayard Street). What started as a pop-up is now a permanent operation, complete with longstanding Mission Chinese favorites like chile-blasted Chongqing chicken wings, kung pao pastrami, and other inventive takes on Sichuan cuisine through his Chinese American lens. The 15-year-old original in San Francisco's Mission District is still open today (though under new ownership). It remains unclear how Bowien plans to zhuzh Buddakan's existing menu full of dim sum, sizzling short ribs, and Beijing duck. Choosing to align with a cash-cow conglomerate of a company like Starr is relatively surprising, considering Bowien's keep-it-tight approach to the restaurant world. Like Mission Chinese, Buddakan has also dealt with past allegations of discrimination and a toxic work culture. Starting as a single location in Philadelphia in 1988, Buddakan grew into a mini empire at its height, with locations in Pennsylvania, New York, and New Jersey. The Meatpacking District location opened in 2006 and, backed by an early two-star review from the New York Times , was an immediate hit. In Manhattan at that time, Buddakan was 'a hipper, younger, clubbier analogue to older, expensive, white tablecloth venues,' former Eater critic Ryan Sutton wrote in a 2015 review. See More: Coming Attractions NYC Restaurant News
Business Wire
an hour ago
- Business Wire
Robotic Pet Company Tombot Secures $6.1M Series A Funding to Support Groundbreaking Health and Senior Care Product Line
LOS ANGELES--(BUSINESS WIRE)-- Tombot, the robotics company that earned widespread acclaim at CES earlier this year for its lifelike robotic puppy, Jennie, announced today the successful close—and oversubscription—of its $6.1 million Series A funding round. Tombot's flagship product, Jennie, was designed specifically to treat the Behavioral and Psychological Symptoms of Dementia (BPSD) and other health issues. 'Tombot is entering a high-demand, underserved market at the intersection of mental health and assistive technology,' said Tombot CEO and Co-Founder Tom Stevens. 'Over 300 million seniors around the world with dementia and mild cognitive impairment are unable to care for a live animal at a time when they need the companionship of a pet more than ever. Millions of other individuals suffering from mental health adversities are in a similar predicament.' With artistic design by Jim Henson's Creature Shop, and developed with the guidance of clinical experts, patients, and their families, Jennie provides many of the health benefits associated with live animal ownership, such as reduced stress and loneliness. Jennie will be used in private homes, assisted living and memory care communities, and other settings where live animals are not always safe or practical. Covered with sensors to respond to touch, voice commands, movement, and other sensory inputs, Jennie is rechargeable, fully cleanable, and comes with an optional caregiver app to customize behaviors and ease the burden of caregiving. With participation from both new and existing investors, the funding round was led by Caduceus Capital Partners, a Nashville-based team of veteran healthcare investors with a primary emphasis on accelerating growth of early-stage digital health startups. 'We identified the growing need for robotic companions several years ago and believe the market is now on the brink of exponential expansion,' said Dave Vreeland, senior managing partner, Caduceus Capital Partners. 'By 2030, the U.S. is projected to have 73 million seniors – an aging population that will increasingly face challenges related to loneliness, companionship, and chronic disease management. These issues are rapidly surpassing the capacity of human caregivers alone. Tombot is uniquely positioned to lead this emerging sector and drive widespread adoption of robotic companions." 'This investment will be rocket fuel for Tombot,' said Stevens. 'We are most appreciative of our company's Board of Directors for their ongoing guidance, and are especially grateful to Caduceus for recognizing and supporting Tombot's mission of creating robotic animals that transform the daily lives of individuals, families, and communities facing health adversities.' According to Stevens, this milestone investment will be used to expand Tombot's team, finalize engineering, complete regulatory and safety certifications, and prepare its first robotic pet for customer shipments to its more than 16,000 pre-order and waitlist customers. About Tombot Tombot, Inc., established in 2017, designs realistic robotic companion animals for individuals unable to safely or practically care for a live animal. After Tom Stevens' own mother's progressive dementia necessitated the rehoming of her beloved pet dog for safety reasons, Tom launched Tombot. Tombot's flagship product, Jennie, was designed specifically to treat the Behavioral and Psychological Symptoms of Dementia (BPSD). The Tombot founding team built a prior startup into one of the world's largest legal automation companies and was successfully acquired.
Yahoo
an hour ago
- Yahoo
SutiSign Enhances eSignature Security with Intelligent ID Verification and 21 CFR Part 11 Compliance
SUNNYVALE, Calif., June 12, 2025 /PRNewswire/ -- SutiSoft leads the way in providing intelligent, cloud-based solutions that transform how businesses operate in a digital world. Today, SutiSoft is excited to announce major enhancements to their electronic signature platform, SutiSign, now featuring dynamic Knowledge-Based Authentication (KBA) and compliance with 21 CFR Part 11 standards. These new features are designed to deliver a smarter, more secure eSigning experience for organizations handling sensitive information and operating under strict regulatory frameworks. With this update, SutiSoft continues its commitment to innovation by integrating intelligent identity verification and regulatory-grade audit capabilities into its already robust eSignature solution. Businesses in highly regulated industries, including healthcare, life sciences, and pharmaceuticals, can now meet compliance mandates while improving signer confidence and process integrity. "Trust and compliance are the foundation of successful digital transactions," said N.D. Reddy, CEO of SutiSoft, Inc. "By introducing AI-powered identity verification and aligning with FDA's 21 CFR Part 11 standards, SutiSign helps businesses manage electronic signatures with confidence, security, and compliance built in from the start." The dynamic Knowledge Based Authentication (KBA) feature uses AI to generate real-time, personalized challenge questions that verify signer identity before granting access to documents. Administrators can define the accuracy level required to pass authentication, set the number of allowed attempts, and control how often a signer can attempt to access the document. These controls ensure that only verified users can view and sign sensitive documents, significantly reducing fraud risk and enhancing security. SutiSign now fully supports 21 CFR Part 11, the FDA regulation that governs the use of electronic records and signatures. The online platform includes secure, time-stamped audit trails that cannot be altered, advanced authentication protocols, and reliable traceability of every action taken on a document. The platform now supports online notarization, allowing users to remotely notarize documents anytime through a trusted notary network. It also integrates with leading payment gateways like Square, Stripe, Clover, and others, enabling users to sign documents and process payments securely in a single step. With these enhancements, SutiSign continues to evolve as a robust, intelligent eSignature platform built for today's compliance-driven business landscape. About SutiSoft SutiSoft develops a comprehensive suite of cloud-based SaaS platforms that streamlines the key business processes for enterprises of all sizes. For more information, please visit our website or call us on 650-969-7884. Contact:CAROL Photo: View original content to download multimedia: SOURCE SutiSoft Inc. Sign in to access your portfolio
